Medicover AB (MCOVb)

Currency in SEK
260.5000
+3.0000(+1.17%)
Real-time Data·
MCOVb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
255.5000260.5000
52 wk Range
179.4000267.0000
Key Statistics
Prev. Close
257.5
Open
258.5
Day's Range
255.5-260.5
52 wk Range
179.4-267
Volume
16.83K
Average Volume (3m)
65.89K
1-Year Change
-0.9506%
Book Value / Share
39.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MCOVb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
261.6030
Upside
+0.42%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Medicover AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 261.6030
(+0.42% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold238.00-8.11%220.00MaintainAug 10, 2026
Deutsche Bank
Hold265.00+2.32%215.00MaintainSep 29, 2025

Medicover AB Earnings Call Summary for Q2/2026

  • Medicover Q2 2026 revenue hit EUR 640.4M, beating estimates by 0.2% with 11.8% organic growth and adjusted EBITDA margin expanding to 17.1%.
  • Operating cash flow surged 28.44% YoY to EUR 73.6M; net leverage improved to 2.9x from 3.6x a year earlier, boosting financial flexibility.
  • India emerged as key growth driver with revenue up 39.6% in local currency, though new hospital startup losses continue pressuring near-term margins.
  • Management reaffirmed 2028 targets of EUR 3.25B organic revenue and EUR 600M adjusted EBITDA, with net leverage below 3.0x and Fee-For-Service focus.
  • Stock rose 1.82% to $224 post-results; company increased credit facility to EUR 400M in May, signaling capacity for continued strategic investments.
Last Updated: 22/07/2026, 09:24
Read Full Transcript

Earnings

Latest Release
Jul 22, 2026
EPS / Forecast
0.16 / 0.17
Revenue / Forecast
640.4M / 639.2M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.56%
Dividend Yield
0.84%
Industry Median 1.27%
Annualised payout
2.17
Paid annually
5-Years Growth
+23.36%
Growth Streak

MCOVb Income Statement

Compare MCOVb to Peers and Sector

Metrics to compare
MCOVb
Peers
Sector
Relationship
P/E Ratio
40.8x19.5x−0.4x
PEG Ratio
0.430.750.00
Price/Book
6.5x2.6x2.6x
Price / LTM Sales
1.4x0.8x3.0x
Upside (Analyst Target)
−5.6%9.8%54.3%
Fair Value Upside
Unlock9.4%7.2%Unlock

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Employees
49000
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
23.22M15.28%5.98B
Other Institutional Investors
94.47M62.16%24.33B
Public Companies & Retail Investors
34.28M22.55%8.83B
Total
151.97M100.00%39.13B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Celox Holding AB31.03%47,157,36512,143,021
Estate Of Jonas Af Jochnick13.02%19,779,9355,093,333

People Also Watch

359.23
LII
+0.04%
20.94
DAST
+1.85%
107.15
CAPP
+2.68%
140.50
ESLX
+1.08%
101.00
ERICb
+1.02%

FAQ

What Is the Medicover (MCOVb) Stock Price Today?

The Medicover stock price today is 260.5000 SEK.

What Stock Exchange Does Medicover Trade On?

Medicover is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Medicover?

The stock symbol for Medicover is "MCOVb."

What Is the Medicover Market Cap?

As of today, Medicover market cap is 39.2100B SEK.

What Is Medicover's Earnings Per Share (TTM)?

The Medicover EPS (TTM) is 0.5612.

When Is the Next Medicover Earnings Date?

Medicover will release its next earnings report on Nov 04, 2026.

From a Technical Analysis Perspective, Is MCOVb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Medicover Stock Split?

Medicover has split 0 times.

How Many Employees Does Medicover Have?

Medicover has 49000 employees.

What is the current trading status of Medicover (MCOVb)?

As of Sep 21, 2026, Medicover (MCOVb) is trading at a price of 260.5000 SEK, with a previous close of 257.5000 SEK. The stock has fluctuated within a day range of 255.5000 SEK to 260.5000 SEK, while its 52-week range spans from 179.4000 SEK to 267.0000 SEK.

What Is Medicover (MCOVb) Price Target According to Analysts?

The average 12-month price target for Medicover is 261.6030 SEK, with a high estimate of 308.96624095 SEK and a low estimate of 234.76693142 SEK. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +0.42% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.